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Abstract
Two components of integrin containing attachment complexes, UNC-97/PINCH and UNC-112/MIG-2/Kindlin-2, were
recently identified as negative regulators of muscle protein degradation and as having decreased mRNA levels in response
to spaceflight. Integrin complexes transmit force between the inside and outside of muscle cells and signal changes in
muscle size in response to force and, perhaps, disuse. We therefore investigated the effects of acute decreases in expression
of the genes encoding these multi-protein complexes. We find that in fully developed adult Caenorhabditis elegans muscle,
RNAi against genes encoding core, and peripheral, members of these complexes induces protein degradation, myofibrillar
and mitochondrial dystrophies, and a movement defect. Genetic disruption of Z-line– or M-line–specific complex members
is sufficient to induce these defects. We confirmed that defects occur in temperature-sensitive mutants for two of the genes:
unc-52, which encodes the extra-cellular ligand Perlecan, and unc-112, which encodes the intracellular component Kindlin-2.
These results demonstrate that integrin containing attachment complexes, as a whole, are required for proper maintenance
of adult muscle. These defects, and collapse of arrayed attachment complexes into ball like structures, are blocked when
DIM-1 levels are reduced. Degradation is also blocked by RNAi or drugs targeting calpains, implying that disruption of
integrin containing complexes results in calpain activation. In wild-type animals, either during development or in adults,
RNAi against calpain genes results in integrin muscle attachment disruptions and consequent sub-cellular defects. These
results demonstrate that calpains are required for proper assembly and maintenance of integrin attachment complexes.
Taken together our data provide in vivo evidence that a calpain-based molecular repair mechanism exists for dealing with
attachment complex disruption in adult muscle. Since C. elegans lacks satellite cells, this mechanism is intrinsic to the
muscles and raises the question if such a mechanism also exists in higher metazoans.
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Introduction
Muscle is a multifunctional tissue [1–4] with a well
appreciated role in locomotion. The contractile properties of
muscle that allow for coordinated locomotion require a complex
protein based machinery [5] and substantial metabolic input
[6]. To balance demand with metabolic cost, the quantity of
muscle protein is controlled by both use and nutrition. The
regulation of muscle protein content is an area of broad interest
owing to the fact that locomotion is an essential part of being
human, the general acceptance that muscle is important for
athletic prowess, and because specific muscle wasting is a
clinical problem. These wasting conditions have substantial
negative impact on mortality [7,8], morbidity, and public health
expenditure [9,10].
Conceptually, muscle size is controlled by signals that regulate
the balance of muscle protein synthesis and degradation. When
bulk protein synthesis exceeds bulk degradation, growth can occur
and when bulk protein degradation exceeds bulk synthesis atrophy
occurs. While there are a number of ways in which a net shift in
balance can lead to atrophy (e.g. protein synthesis and degradation
can each go up or down together or independently and/or to
different degrees), degradation is required for atrophy to occur.
Four main proteolytic systems, the proteasomes [11,12], lysosomes
[13], calpains [14], and caspases [15], have been identified as key
players in the regulation of muscle size and function. However,
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of how their activities are regulated by the vast array of extra-
muscular signals which appear to control muscle size [16].
Our laboratories have developed the soil nematode Caenorhabdi-
tis elegans, a validated muscle and systems biology model, into a
model for the discovery of regulatory signals of muscle protein
degradation. As with mammalian muscle, protein degradation in
C. elegans is observed in response to starvation [17], denervation
[18], or disruption of endocrine signalling [19,20]. Motor neurons
release acetylcholine, which acts to inhibit proteasome based
degradation in post-synaptic muscle. When animals are starved or
‘‘genetically denervated,’’ proteasome based degradation occurs
unless the animals are supplemented with cholinergic agonist
[17,18]. Additionally, muscle itself releases Fibroblast Growth
Factor [21] which acts to activate autophagic degradation [19].
This constitutive degradation is prevented when Insulin/Insulin-
like Growth Factor, from an unknown source, counterbalances the
Fibroblast Growth Factor signalling within muscle [20]. Thus, we
have begun to gain a picture of the integrated control of muscle
protein degradation in C. elegans muscle. Open questions include
how calpains and caspases are regulated by extra-muscular signals
and how many intra-muscular signalling networks control these
four proteolytic systems.
Recently it was shown that gene expression in C. elegans muscles
responds similarly to mammalian muscle gene expression during
spaceflight, with several key genes (for example, MyoD and
myosin heavy chain) showing similar changes [22]. Two of the
roughly 150 muscle genes which were identified as being down
regulated in response to spaceflight, unc-97 [23] and unc-112 [24],
produce proteins that are part of integrin containing muscle
attachment complexes. Integrin-based attachment complexes are
essential for proper muscle development [25], show changes in
protein content in response to loading and unloading [26],
modulate load induced changes in muscle protein synthesis [27],
and serve various other essential cellular functions (reviewed in
[28]). A recent genomic screen also uncovered unc-97 and unc-112
as negative regulators of muscle protein degradation [29]. These
observations prompted us to investigate if these attachment
complexes, as a whole, functioned as negative regulators of muscle
protein degradation in fully differentiated muscle. To do this, we
used RNAi to knock down the gene products of the core complex
components [28,30–32]: the extracellular ligand, UNC-52/
Perlecan; the receptor, PAT-2/Integrin alpha and PAT-3/
Integrin beta; and intracellular partners, found at both the Z
and M-lines [31,32], PAT-4/Integrin linked kinase, PAT-6/
Actopaxin, UNC-112/MIG-2/Kindlin-2, and UNC-97/PINCH.
We also used RNAi to knock down a sub-set of gene products that
are peripheral components of the complex. For this we chose: the
Z and M-line proteins TLN-1/Talin and ZYX-1/Zyxin [31–33];
the Z-line specific proteins ATN-1/alpha actinin and DEB-1/
Vinculin [31,32]; and the M-line specific proteins UNC-82 and
UNC-89/Obscurin [31,32,34,35]. As an alternative hypothesis to
the complexes as a whole regulating muscle protein degradation,
we also tested a known binding partner of UNC-112, UIG-1 [36]
and the Rho GTPase, CDC-42, for which UIG-1 is a guanine
nucleotide exchange factor [36].
Here we report that integrin attachment complexes are required
for proper maintenance of adult muscle and that failure to
maintain these complexes results in activation of calpain proteases,
general degradation of soluble muscle proteins, myofibrillar and
mitochondrial dystrophies, and a severe movement defect.
Because the integrin attachment complex member DEB-1/
Vinculin is degraded by these activated calpains, we postulate
that calpain activation in response to disruption of integrin
attachment complexes allows for the reassembly and/or repair of
these complexes. In normal adult C. elegans, complex disruption
may occur as the result of increased mechanical strain and/or
failure of other mechanisms to properly coordinate growth of
muscle and adjacent hypodermal cells. Thus, calpains help adult
muscle maintain both structural integrity and cross tissue
communication.
Results
Acute genetic disruption of either Z- or M-line muscle
attachment complexes results in protease activation
In fully developed adult worms, acute RNAi treatment against
any one of fourteen genes that encode integrin muscle attachment
complex components resulted in loss of a transgene-encoded LacZ
reporter of muscle protein degradation in the cytosol (Figure 1A).
Because this reporter protein is synthesised only until adulthood
[17] and remains stable for the next 72 to 96 hours in well-fed
wild-type animals [18–20,37,38], loss of reporter indicates that
proteases have been activated and degradation is occurring. As
RNAi against the core complex components PAT-2, PAT-3, PAT-
4, PAT-6, UNC-52, UNC-97, and UNC-112 all yielded protein
degradation, it appears that protease activation occurs in response
to disruption of the core integrin complex. Consistent with this,
RNAi against peripheral components located at both the Z and
M-line (TLN-1 and ZYX-1), only the Z-line (ATN-1 and DEB-1),
or only the M-line (UNC-82) results in protein degradation. Thus,
genetic disruption of either Z-line or M-line specific components is
sufficient to result in protease activation. These results suggest that
sustained disruption of any integrin containing complex results in
activation of a protease in adult C. elegans muscle.
RNAi knock down of one of the fifteen genes tested, unc-89,a
known M-line attachment complex component [39], did not
provoke degradation of our transgenic reporter. Below, we report
that RNAi against UNC-89 does yield a movement defect and also
disruption of the normally arrayed sarcomeres in 100% of animals
examined (see below, Figure 2 and Figure 3). Thus, the lack of
degradation is not simply due to lack of an effective RNAi
treatment. From these results we tentatively conclude that reduced
amounts of UNC-89 are not sufficient to cause sustained protease
activation. However, additional studies are required to (dis)prove
the role of reduced levels of UNC-89 with respect to sustained, or
Author Summary
Muscle is a dynamic tissue that grows in response to use
and nutrition and shrinks in response to lack of use, poor
nutrition, or disease. Loss of muscle mass is an important
public health problem, but we understand little of the
genes that regulate muscle shrinkage. We have found that,
in adult worm muscle, attachment to the basement
membrane is continuously required to prevent catastroph-
ic sub-cellular defects that result in impaired ability of
muscle to function. We have also identified a group of
proteases that are activated when the attachment fails to
be properly maintained. Conversely, when these proteases
are lacking in adult muscle, the muscles fail to maintain
attachment to the basement membrane. Thus, we have
discovered a group of proteases that appear to act to
maintain attachment to the basement membrane and
therefore to maintain muscle itself. Because these worms
lack satellite cells, this maintenance system is intrinsic to
muscle, thus raising the question whether a similar or
identical system also works in humans.
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sub-cellular pathologies seen in response to unc-89 RNAi treatment
(see below) coupled with the lack of observed degradation of LacZ
suggests that UNC-89 acts as a key molecule in the intramuscular
maintenance of the normal arraying of attachment complexes.
Sustained disruption of muscle attachment complexes
results in general degradation of soluble proteins
Past studies have shown that when the transgene-encoded LacZ
reporter utilised here is degraded, so are other transgene-coded
proteins expressed in muscle and so are endogenous cytosolic
muscle proteins such as arginine kinase (the worm equivalent of
creatine kinase)[17,19,20,37,38].Thus,theLacZproteinreports on
general rather than protein-specific degradation in the muscle
cytosol. To confirm that the degradation observed in response to
genetic disruption of the integrin complexes was not specific for
LacZ, we treated animals containing cytsosolic Green Fluorescent
Protein (GFP) or cytosolic DsRed reporters with RNAi against unc-
97 or unc-112 (the other genes in Figure 1A were not tested). As
expected, GFP and DsRed were also degraded (not shown). We did
not observe GFP or DsRed leaking out of the muscle during RNAi
treatment (not shown), further confirming that the decrease in
reporter protein content is the result of intramuscular degradation
rather than loss of cytosol due to impaired membrane maintenance.
As RNAi is a relatively new technology, we also confirmed the
RNAi results utilizing mutants. We tested temperature sensitive
mutants in two members of this attachment complex, UNC-52/
Perlecan (an integrin ligand in the basement membrane) [40] and
UNC-112/Kindlin-2 (an intramuscular binding partner of the
integrin receptor) [24]. As shown in Figure 1C, acute temperature
shift of fully developed adult animals results in protein degradation
in both unc-52
ts and unc-112
ts mutants but not in wild-type animals.
Degradation of the pre-existing LacZ reporter was confirmed by
western blot analysis (Figure 1D and 1E). Degradation was not
observed in unc-112
ts animals when unc-112
+::GFP was also present
(not shown). Whole body protein, as assessed in triplicate 30 worm
samples by coomassie staining and quantified in ImageJ, was
reduced in unc-112
ts mutants, but not wild-type animals, 48 hours
post temperature shift (17%+/28% loss vs. 40%+/29% gain,
P,0.001 two way repeated measures ANOVA). The decline in
total protein in unc-112
ts mutants further supports the inference
that sustained genetic disruption of integrin attachment complexes
results in sustained activation of a protease, which results in
general degradation of soluble muscle protein.
RNAi knockdown reduces the amount of normal gene product
whereas the temperature sensitive mutants produce proteins that
are structurally and functionally abnormal. Therefore, the
similarity of muscle phenotypes (more are reported below) suggests
that the trigger for these phenotypes is the reduction of attachment
complex function, rather than just aberrant assembly during RNAi
knockdown. We believe that a severe reduction of function is
required, because we found that unc-112
ts/+heterozygotes at 25uC
did not degrade LacZ reporter and showed no signs of sarcomere
disorganisation (not shown). Additionally, degradation was
prevented in unc-112
ts; unc-112
+::GFP animals that had low enough
levels of GFP to be undetectable on our epifluorescent microscope
(not shown). Thus, the observed degradation of cytosolic protein
content may represent the consequence of catastrophic failure of
the attachment complexes and/or sustained inability to reassemble
partially functional complexes.
Protein degradation in response to muscle attachment
complex disruption does not require synthesis of
proteases
We next asked whether the reporter degradation was carried
out by activation of proteases newly synthesized after disruption of
the attachment complexes, or by activation of pre-existing
protease(s). We conducted the same temperature shift experiments
described above in the presence of the protein synthesis inhibitor
cycloheximide (CHx) and found that degradation was indeed
occurring (Figure 1C: unc-52
ts or unc-112
ts+CHx). This result
suggests that pre-existing proteases are sufficient to account for the
protein degradation observed in response to disruption of the
integrin complexes.
dim-1 mutants do not display protein degradation in
response to acute RNAi treatment targeting core
attachment complex members
The fact that the gene products (Figure 1A) occur together in
attachment complexes does not uniquely establish that a common
mechanism is responsible for the common catabolic response to
knockdown of any of these proteins. We therefore asked if the
response to the various knockdowns could be suppressed by
mutation in a single gene. In a screen for second-site mutations
that suppress the movement defect of unc-112 mutants, only
mutations in dim-1 were recovered and characterized [41]. dim-1
encodes a novel immunoglobulin-like repeat protein that localizes
aroundand between,butnotwithin,Z-lines[42].RNAiknockdown
of any attachment complex gene in a dim-1 mutant background
showed no obvious LacZ degradation (Figure 1B). Temperature
shift experiments on unc-112
ts mutants in a dim-1 mutant
background (Figure 1C) also did not show obvious degradation
and western blot analysis confirmed that degradation was
Figure 1. Acute loss of integrin-based attachment induces general cytosolic protein degradation via a common mechanism. A) Age
synchronised wild-type L1 larvae were grown to young adulthood at 16uC (t=0 h) before transferring to NGM RNAi plates [87] seeded with bacteria
expressing dsRNA against genes indicated for an additional 72 h (mid-adulthood) at 20uC. The blue stain that appears as circles in the centre of
t=72 h animals is stain in muscles of developing embryos (for example+pat-2 and deb-1 RNAi). The blue stain that appears as lines in the t=72 h
animals is indicative of lacZ expressing bacteria in the gut (typically near the head, for example+unc-112 RNAi). B) dim-1(ra102) mutants were cultured
identically to A. C) Wild-type, unc-52
ts, unc-112
ts, unc-112
ts; dim-1(gk54), and unc-112
ts; dim-1(ra102) animals were age synchronised at L1 stage and
grown to young adulthood (t=0 h) at 16uC, and cultured for an additional 72 h at either 16uC (permissive temperature for the mutation) or 25uC
(non-permissive temperature). unc-52
ts and unc-112
ts animals were also cultured under the same conditions in the presence of cycloheximide (+CHx)
at 400 mg/ml. In A, B and C approximately 20–30 animals were stained for b-galactosidase activity (blue) at t=0 h and after 24 h, 48 h (not shown)
and 72 h. D) Representative immunoblot analysis of 146-kDa b-galactosidase fusion protein in 30-worm lysates, cultured under the same conditions
as in C after temperature-shift to 25uC only. All experiments in A, B, C and D were repeated a minimum of three times. E) Kinetics of loss of b-
galactosidase protein from 16uC (t=0 h) after temperature-shift to 25uC in wild-type (solid line), unc-52
ts (large dashed line) or unc-112
ts (small dashed
line) animals. *,**Significant difference between unc-112
ts versus wild-type (P,0.01, P,0.001). {Significant difference between unc-52
ts versus wild-
type (P,0.01). F) Kinetics of loss of b-galactosidase protein from 16uC (t=0 h) after temperature-shift to 25uCi nunc-112
ts (small dashed line), unc-
112
ts; dim-1(gk54) (large dashed line) or unc-112




ts; dim-1(ra102) (P,0.001). Values in E and F are the average of three immunoblots 6 SEM. Level of significance in all indicated
cases from two way repeated measures ANOVA. Scale bars represent 100 mm.
doi:10.1371/journal.pgen.1002471.g001
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the RNAi results, suggesting that the protein degradation induced
by impaired muscle attachment acts via a common mechanism,
regardless of which component of the attachment complex is
knocked down. Our data indicate that integrin based attachments
are not only important for proper development of muscle, they are
also essential to maintenance of cytosolic muscle protein content.
Acute genetic disruption of muscle attachment
complexes results in a movement defect in wild-type but
not dim-1 mutants
To determine whether attachment complex disruption had
additional effects on adult muscle cells, we next examined gross
movement. Disruption of integrin-based attachment complexes by
mutation (Figure 2A) or RNAi knockdown of any one of the
attachment complex genes tested (Figure 2B) also leads to a decline
in animal mobility. Although the unc-112
ts mutants are not fully
normal in movement rate even when grown at the ‘‘permissive’’
16uC, they show a pronounced loss of mobility within 24 h after a
shift to 25uC. This does not occur in unc-112
ts/+heterozygotes
(Figure 2A) or unc-112
ts; unc-112
+::GFP animals where the GFP is
not visible (not shown). This implies that the attachment complexes
function at least mostly normally when wild-type and mutant UNC-
112 molecules, which presumably mix randomly during attachment
complex assembly, are present. This also implies that the
phenotypes of unc-112
ts mutants likely derive from a reduction in
the function of pre-formed attachment complexes upon an increase
in temperature, and that reduction of UNC-112 function to 50% of
normal (the presumed situation in a heterozygote) is not sufficient to
disrupt function of the attachment complexes. The functional
consequences of RNAi knockdowns in adult animals (Figure 2B)
must be understood in this light and further suggest a dynamic state
of the attachment complexes in adult animals.
The largest declines in movement following 72 hour treatment
with RNAi were observed for the treatments targeting core integrin
complex members (PAT-2, PAT-3, PAT-4, PAT-6, UNC-52,
UNC-97, UNC-112). These declines are significantly different than
for all more peripheral complex members other than CDC-42 and
TLN-1. This suggests that genetic disruption of the core complex
members, which are found at all attachment sites, has more severe
functional consequences than disruption of the more peripheral
and/or Z or M-line specific components. However, caution should
be applied when analysing quantitative differences between defects
seen in response to non-quantitative genetic disruption of multi-
protein complexes for which the in vivo stoichiometries and protein
to protein binding affinities are not known.
We also tested if the movement defect was suppressed in dim-1
mutants. These mutants, without RNAi treatments, move
somewhat more slowly than wild-type animals, yet do not show
further depression of movement upon RNAi knockdown of many
of the genes whose knockdown cause the greatest movement
impairments in wild-type (for example the core complex, compare
Figure 2B and 2C). This finding is in line with previous reports
that impaired basal movement can prevent functional decline in
muscular dystrophy gene mutants [43,44].
Acute genetic disruption of muscle attachment
complexes results in disorganisation and collapse of
arrayed sarcomeres
Acute RNAi treatment targeting each of the muscle attachment
complex genes tested causes myofibrillar defects (Figure 3, Figure
S1). However, the myofibrillar defects observed in response to
knockdown of each complex member vary considerably in severity
Figure 2. Acute loss of muscle attachment results in a
movement defect that does not occur in dim-1(ra102) mutants.
A) Age synchronised wild-type (+/+), unc-112
ts heterozygotes (+/2) and
unc-112
ts homozygotes (2/2) were grown to young adulthood at 16uC
(t=0 h) and cultured after temperature-shift to 25uC (mutation active
temperature) for an additional 72 h. At t=0 h, 24 h, 48 h and 72 h
animals were analysed for movement rate by placing animals in BU
buffer and counting the number of sinusoidal movements completed in
one minute. Values shown are the average 6 SEM of 5 animals
measured 10 times to give a total of 50 independent measurements.
**Significant movement decrease versus +/+ and +/2 at respective time
point (P,0.001). B) Wild-type and C) dim-1(ra102) animals were grown
to young adulthood and cultured on RNAi plates [87] against genes
indicated on x-axis for an additional 72 h. Movement rate was
measured as in A at t=0 h and 72 h. Values shown are the average
6 SEM of 10 animals measured 10 times to give a total of 100
independent measurements. **Significant movement decrease on
respective RNAi treatment at 72 h versus wild-type control (P,0.001).
{{Significant movement decrease in dim-1(ra102) mutants versus wild-
type controls at 72 h (P,0.001). All experiments were repeated at least
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and reproducibility of defects, we took advantage of the fact that
defects typically appeared as either aggregates of myosin::GFP that
had a ball like appearance (Example: pat-3, Figure 3), as tears in
myofibrils (Example: unc-52, Figure S1), or disruption of the
normal arraying of sarcomeres (Example: unc-89, Figure 3). Using
this classification scheme it appears that all members of the core
complex (PAT-2, PAT-3, PAT-4, PAT-6, UNC-52, UNC-97 &
UNC-112) are required in adult muscle to prevent the collapse of
arrayed sarcomeres into ball like structures, and that the Z and M-
line peripheral components (TLN-1 & ZYX-1) and M-line specific
components (UNC-82 and UNC-89) are required in adult muscle
to prevent disorganisation of arrayed sarcomeres. In contrast, the
Z-line specific components (ATN-1 and DEB-1) do not appear to
be as stringently required to prevent disorganisation or collapse of
arrayed sarcomeres, inasmuch as the defects observed are not
statistically significant (P.0.05, two way repeated measures
ANOVA). Results from RNAi targeting the genes we selected as
a potential unc-112 interacting signalling system (uig-1 & cdc-42)
suggest that CDC-42 is required in adult muscle to prevent
disorganisation of arrayed sarcomeres.
The variable severity we observed in disrupted sarcomere
structure in adult muscle parallels the variable severity previously
observed during development, where mutations in a number of the
core complex genes produce both embryonic lethality and collapse
of arrayed sarcomeres into ball like structures [45]. The similarity
in phenotype in embryonic lethal mutants and fully developed
adult muscle further supports the notion that these attachment
complexes are dynamic in adult muscle. Our data also confirm
past reports of the role of some of these genes in myofibril
maintenance [36,46,47] and support the conjecture, raised in
Drosophila, that integrin based attachment complexes, as a whole,
are required for myofibrillar maintenance [48]. By using GFP
fused to full-length myosin, we have observed torn myofibrils in
live adult animals with acutely impaired muscle attachment
complexes. These observations are consistent with previous studies
of animals with mutations in two of these complex members,
UNC-112 and UNC-97, where impaired resistance to mechanical
damage was noted [23,41]. Taken together, these observations
appear to support the notion that the integrin attachment
complexes are important in force transmission and that loss of
Figure 3. Acute loss of muscle attachment causes disorganisa-
tion and collapse of arrayed sarcomeres. Animals expressing a full
length translational fusion of gfp to myo-3 (myosin heavy chain A) were
age synchronised at L1 stage and grown to young adulthood at 16uC
(t=0 h). Adult animals were then transferred to NGM RNAi plates [87]
seeded with bacteria expressing dsRNA against genes indicated for a
further 72 h to mid-adulthood. The 20 most Unc animals were picked
and scored for identical defects in sarcomere structure in at least two
muscles within the animal and this was repeated for 5 independent
RNAi treatments (n=100 animals per condition/time point). A)
Percentage of animals where only normal arrays of sarcomeres were
observed is displayed as average 6 SEM. Below the graph is an example
of an RNAi treated animal displaying normal arrays of sarcomeres (as
indicated by straight parallel lines of GFP), these are enlarged 300% to
the right of the micrograph. B) Percentage of animals where
disorganisation of sarcomere arrays were observed is displayed as
average 6 SEM. Below the graph is an example of an RNAi treated
animal displaying disorganised arrays of sarcomeres (as indicated by
lack of straight parallel lines of GFP), these are enlarged 300% to the
right of the micrograph. C) Percentage of animals where sarcomere
arrays have collapsed into ball like structures is displayed as average 6
SEM. Below the graph is an example of an RNAi treated animal
displaying a collapsed array of sarcomeres (as indicated by parallel lines
of GFP that are not straight, long, lines), these are enlarged 300% to the
right of the micrograph. A sample image of an RNAi treatment against
each gene can be found in Figure S1, not displayed here are animals
with tears in the arrayed sarcomeres (see unc-52 in Figure S1).
**Significant difference from control t=72 h, P,0.001 (two way
repeated measures ANOVA). Scale bars represent 15 mm.
doi:10.1371/journal.pgen.1002471.g003
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quent collapse, of the arrayed sarcomeres [43].
We utilized the same full length translational fusion of gfp to myo-
3 (myosin heavy chain A) to confirm that arrayed sarcomeres were
disrupted in unc-112
ts mutants (see below). We also confirmed that
actin filaments are torn in fixed unc-112
ts mutant animals stained
with RITC-phalloidin at 24 hrs post temperature shift (not
shown). In contrast to the general degradation of soluble cytosolic
protein seen in unc-112
ts mutant animals (Figure 1C–1F), we did
not observe degradation of either myosin heavy chain or actin in
western blots of unc-112
ts mutant animals (not shown). Thus, the
dystrophic appearance of sarcomeres in these animals largely
represents dystrophy of the sarcomeres and not their degradation.
These results suggest that it is degradation of soluble/freely
accessible protein that is triggered by attachment complex
disruption, and not degradation of insoluble/inaccessible protein.
If collapsed arrays of sarcomeres can be repaired or replaced, it
may be that other repair or proteolytic processes must be activated
(for example in mammalian muscle, physical disruption of the
sarcomere has been postulated to result in activation of alpha-
crystallin mediated repair [49] and also proteasome mediated
degradation [50]). Given the complexity of the sarcomere, it is
quite likely that multiple proteolytic and repair processes
contribute to sarcomere maintenance.
Acute genetic disruption of muscle attachment
complexes results in disorganisation and fragmentation
of the mitochondrial network
Acute RNAi treatment targeting each of the muscle attachment
genes also results in mitochondrial fragmentation (Figure 4, Figure
S2), suggesting that the capability for energy production in muscle
may be impaired [51]. For each of the RNAi treatments, the
observed mitochondrial defects varied in severity and reproduc-
ibility. To quantify the extent and reproducibility of these defects,
we took advantage of the fact that defects typically appeared to
have different extents of fragmentation or disorganisation of the
mitochondrial network. We classed animals with more than 90%
loss of the mitochondrial network as severe fragmentation
(Example: pat-4, Figure 4), those with more 30–80% loss as
moderate (Example: unc-52, Figure 4), or as having a disorganised
mitochondrial network (Example: uig-1, Figure 4). Using this
classification scheme it appears that all members of the core
complex (PAT-2, PAT-3, PAT-4, PAT-6, UNC-52, UNC-97 &
UNC-112) are required in adult muscle to prevent fragmentation
of the mitochondrial network (Figure 4). This is the same set of
genes that is also required to prevent collapse of arrayed
sarcomeres into ball like structures. Data from the other genes
tested continues to show a parallel between the genes required in
adult muscle to prevent sarcomere disorganisation and mitochon-
drial fragmentation/disorganisation with the Z and M-line
peripheral components (TLN-1 & ZYX-1) and the M-line specific
components (UNC-82 & UNC-89) being required in adult muscle
to prevent both pathologies (Compare Figure 3A and Figure 4A).
Again, RNAi against the genes we selected as a potential unc-112
interacting signalling system (uig-1 & cdc-42) produced significant
defects, suggesting CDC-42 is required in adult muscle to prevent
mitochondrial disorganisation. In contrast, the Z-line specific
components (ATN-1 and DEB-1), which are not required for
maintenance of arrayed sarcomeres, do appear to be required to
prevent mitochondrial disorganisation. We also confirmed that
severe mitochondrial fragmentation occurs in unc-112
ts mutants
(see below). Understanding how disruption of muscle attachment
results in disorganisation and fragmentation of the mitochondrial
network will require further studies. It could be that these defects
are caused by disorganisation and/or collapse of the cytoskeleton,
to which mitochondria are physically tethered [52], and/or
acidification of the cytosol [53], as the result of activation of ion
channels following loss of attachment to the basement membrane
[54].
Acute genetic disruption of core members of muscle
attachment complexes results in collapse of arrayed
attachment complexes into ball like structures
As shown in Figure 5, RNAi against the core complex members
(PAT-2, PAT-3, PAT-4, PAT-6, UNC-52, UNC-97, UNC-112)
results in degradation of the LacZ reporter protein, a marked
decline in mobility, collapse of arrayed sarcomeres into ball like
structures, and severe mitochondrial fragmentation. The severity
of the sarcomere and mitochondrial phenotypes in response to
knockdown of the core complex is significantly different than for
non-core complex members (P,0.001, two way repeated
measures ANOVA). This may suggest that more severe disruption
of the attachment complexes occurs in response to these
treatments. UNC-95::GFP localizes to the attachment complexes
[55], allowing us to examine attachment structure, in vivo,i n
response to RNAi treatment against the attachment complex
components. We find a statistically significant collapse of the
arrayed attachment complexes into ball like structures in response
to RNAi against the core complex members (PAT-2, PAT-3,
PAT-4, PAT-6, UNC-52, UNC-97, UNC-112) but not the other
peripheral components tested (Figure 5, Figure S3, P,0.001, two
way repeated measures ANOVA); untreated animals display
normal arraying of attachment complexes and these grow in size,
but not number, with increasing age (Figure S4). Thus, it does
appear that RNAi against the core complex results in a more
severe disruption of the attachment complexes themselves. This
disruption likely causes the collapse of the arrayed sarcomeres into
similar ball like structures. Of note, RNAi against the M-line
component UNC-89 also produces significant disorganisation of
the attachment complexes, whereas the RNAi against the other
genes tested does not (Figure 5, Figure S3, P,0.001, two way
repeated measures ANOVA). It may be the case that this
disorganisation accounts for the lack of LacZ degradation
observed in response to RNAi against unc-89; further studies are
clearly needed. Other relationships among the various phenotypes
observed in response to attachment complex disruption are
discussed below.
Loss of DIM-1 protects against attachment complex
disruption and resultant intramuscular pathologies
The general correlation between the phenotypes studied, and
the lack of degradation and movement decline in response to acute
disruption of attachment complexes in dim-1 mutants, prompted us
to further examine if loss of DIM-1 could mitigate the effects of
attachment disruption. Chronic growth of unc-112
ts mutants on an
RNAi feeding vector against dim-1 was sufficient to inhibit collapse
of arrayed sarcomeres into ball like structures (Figure 6A) and the
extent of mitochondrial fragmentation in unc-112
ts mutants
(Figure 6B). In neither case were the untreated unc-112
ts mutants
fully normal at 16uC but in both cases the unc-112
ts defects were
suppressed at 16uC and following temperature upshift to 25uC.
Consistent with the past report for unc-112; dim-1 double mutants,
we find both the arrayed sarcomeres and the attachment
complexes disorganised with an appearance similar/identical to
that of dim-1 single mutants [41].
Given that either mutation in or RNAi against dim-1 is capable
of suppressing all of the effects of acute genetic disruption of
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disruption of the attachment complexes themselves. Given that
attachment complexes are disorganised (e.g. not nicely arrayed Z
and M lines) in dim-1 mutants, we opted to determine if loss of dim-
1 could prevent the collapse of attachment complexes into ball like
structures (as observed in response to RNAi against the core
complex members (PAT-2, PAT-3, PAT-4, PAT-6, UNC-52,
UNC-97, UNC-112 (Figure 5, Figure S3)). Several lines of
evidence suggest that loss of dim-1 does prevent or delay the
collapse of the arrayed attachment complexes into ball like
structures. First, adults expressing UNC-112
+::GFP display
collapsed complexes following acute treatment with RNAi
targeting pat-2 (Example: +pat-2 RNAi, Figure 6C) and the
number of animals showing such disruption is significantly
Figure 4. Loss of muscle attachment results in mitochondrial fragmentation. Animals expressing GFP-tagged mitochondria were age
synchronised at L1 stage and grown to young adulthood at 16uC (t=0 h). Animals were then transferred to NGM RNAi plates [87] seeded with
bacteria expressing dsRNA against genes indicated for an additional 72 h (mid-adulthood) at 20uC. The 20 most Unc animals were picked and scored
for identical defects in mitochondrial structure in at least two muscles within the animal and this was repeated for 5 independent RNAi treatments
(n=100 animals per condition/time point). A) Percentage of animals where only networked mitochondria were observed is displayed as average 6
SEM. Below the graph is an example of an RNAi treated animal displaying networked mitochondria (as indicated by the largely continuous parallel
lines of GFP), these are enlarged 300% to the right of the micrograph and look arrayed like the sarcomeres (compare to enlargement in Figure 3A). B)
Percentage of animals where disorganisation of the mitochondrial network was observed is displayed as average 6 SEM. Below the graph is an
example of an RNAi treated animal displaying disorganisation of the mitochondrial network (as indicated by the lack of parallel lines of GFP), these
are enlarged 300% to the right of the micrograph. C) Percentage of animals where moderate fragmentation (.30%) of the mitochondrial network is
observed is displayed as average 6 SEM. Below the graph is an example of an RNAi treated animal displaying moderate fragmentation of the
mitochondrial network (as indicated by the largely non-continuous parallel lines of GFP), these are enlarged 300% to the right of the micrograph. D)
Percentage of animals where severe fragmentation (.90%) of the mitochondrial network is observed is displayed as average 6 SEM. Below the graph
is an example of an RNAi treated animal displaying severe fragmentation of the mitochondrial network (as indicated by sparse GFP puncta), these are
enlarged 300% to the right of the micrograph. A sample image of an RNAi treatment against each gene can be found in Figure S2. *, **Significant
difference from control t=72 h, (P,0.01, P,0.001 two way repeated measures ANOVA). Scale bars represent 15 mm.
doi:10.1371/journal.pgen.1002471.g004
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parallel (Figure 6C). Second, adults expressing UNC-95::GFP
display substantial collapse of complexes following acute treatment
with RNAi targeting unc-112 (Example: +unc-112 RNAi,
Figure 6D). This is not observed in dim-1 mutants expressing
UNC-95::GFP following identical treatment in parallel
(Figure 6D). Third, adult progeny of UNC-95::GFP expressing
worms grown for two generations on RNAi targeting dim-1 do not
display collapsed complexes when later acutely treated with RNAi
targeting unc-112 (Figure 6D). Together, these results suggest that
the disorganised array of attachment complexes observed in dim-1
mutant animals are resistant to the effects of genetic disruption of
the attachment complexes and that this decreased severity of
attachment complex disruption in dim-1 mutants accounts for the
fact that dim-1 mutants do not display protein degradation,
movement decline, collapse of the arrayed sarcomeres, or severe
mitochondrial fragmentation in response to RNAi treatments
targeting the complexes.
Acute genetic disruption of attachment complexes
triggers calpain-mediated protein degradation
The genomic screen that identified unc-97 and unc-112 RNAi
treatment as inducing protein degradation in adult C. elegans
muscle demonstrated that in both cases, degradation could not be
blocked by treatment with the proteasome inhibitor MG132 and
occurred in mutants that block pro-autophagy signalling in C.
elegans [29]. We confirmed and extended these results. As shown in
Figure 7A, degradation in response to loss of UNC-112 was not
prevented by treatment with levamisole (Lev), an acetylcholine
agonist, nor by MG132 (ZLLL), a proteasome inhibitor, either of
which inhibits proteasome based degradation in response to loss of
motor neuron input in C. elegans [18]. Similarly, degradation was
not prevented by SB201290, a MAPK inihibitor that blocks pro-
autophagy signalling that results from an imbalance in growth
factor signalling in C. elegans [19,20,37]. All compounds were used
at concentrations that did block degradation in appropriate
control animals and all compounds also failed to block degradation
in unc-52
ts mutant animals (not shown). Because autophagic
degradation in response to loss of IGFR or gain of FGFR
signalling also induces a severe movement defect in C. elegans
[19,20,37], we tested the involvement of this pathway further. We
further found that RNAi against unc-112 or unc-97 induces
degradation in the genetic background of mek-2 or mpk-1 reduction
of function mutations, which block signalling for autophagic
degradation [19,37], and found no increase in activated pTpY-
MPK-1 MAPK in unc-112 mutants at nonpermissive temperature
(not shown). Similarly, mpk-1 or mek-2 RNAi did not suppress
protein degradation in unc-112
ts or unc-52
ts mutants (these RNAi
treatments did suppress degradation in clr-1
ts and let-60
ts mutants,
not shown). Finally, N6,N6-dimethyladenosine, a direct inhibitor
of autophagy [56], failed to block degradation in unc-112
ts or unc-
52
ts mutants (this compound did suppress degradation in daf-2
ts
mutants, not shown). Thus, our results indicate that degradation
observed in response to loss of integrin based attachment does not
appear to require either the ubiquitin-proteasome or the
autophagic pathways in C. elegans.
We therefore tested if caspases or calpains were likely to be
involved. The degradation seen in response to acute RNAi
treatment against unc-97 or unc-112 was not suppressed in a ced-3
(caspase 3) mutant (Figure 7B). In contrast, acute treatment with
calpain inhibitors did suppress protein degradation in unc-112
ts
and unc-52
ts mutants (Figure 7C and 7D) and chronic growth on
RNAi against calpain genes (clp-1, clp-4, tra-3, clp-6 or clp-7) was
also sufficient to block degradation in these mutants (Figure 7C
and 7D). Together these results suggest that calpains are activated
in response to genetic disruption of integrin containing attachment
complexes and that inhibition of this activity can block the general
degradation of soluble cytosolic proteins. Only clp-1 [57] and clp-4
[58] have previously been reported to be expressed in C. elegans
muscle. We were therefore concerned that RNAi against one clp
gene might result in knockdown of several clp gene products.
However, a comparison of the nucleotide sequences of all clp gene
primary transcripts indicates that there is no region of sequence
identity that extends even to 21 nucleotides, making it unlikely that
any one clp RNAi treatment affects multiple clp genes. Thus, it may
be that several calpains are activated in response to genetic
disruption of integrin attachment complexes in C. elegans muscle.
Because we knew that RNAi against a combination of protease
encoding genes can effectively block protein degradation in muscle
[59], we tested if RNAi against a combination of clp genes could
Figure 5. Acute loss of core integrin attachment complex
members leads to collapse of attachments and multiple
pathologies. Collapse of attachment complexes into ball like
structures was assessed (Figure S3) and compared with the severity
of other pathologies associated with attachment complex disruption
(Figure 1, Figure 2, Figure 3, Figure 4, and Figures S1 and S2).
Pathologies identified as significantly different from matched controls
(t=72 h, P,0.001 two way repeated measures ANOVA) were placed
into identical groupings based upon severity of defect. In the case of
the movement defect the extent of severity was established as follows.
First, the core complex members were considered as a group and
examined against the remaining components for lack of significant
difference from any member of the group (t=72 h, P.0.05 one way
ANOVA). Next, the remaining components were examined for groups of
components where a significant difference between individual compo-
nents within a group of components did not exist (t=72 h, P.0.05 one
way ANOVA) but a significant difference between every member of the
group and all other components did exist (P,0.01, one way ANOVA).
Thus, the colour coding for the extent of pathology as displayed in the




PLoS Genetics | www.plosgenetics.org 9 January 2012 | Volume 8 | Issue 1 | e1002471Figure 6. Loss of dim-1 suppresses attachment complex collapse and resulting pathologies. Where dim-1 RNAi was employed, indicated
animals (wt or unc-112
ts) were grown on RNAi targeting dim-1 for two generations and remained on dim-1 RNAi plates through the experiment. Age
synchronised L1 stage indicated animals (wt, unc-112
ts,o rdim-1(ra102)) were gown to young adulthood at 16uC (t=0 h) before being temperature
shifted to 25uC and cultured for a further 72 h. 20 animals were picked and scored for identical pathology in at least two muscles at t=0 h, 24 h,
48 h, and 72 h. A) Displayed are the percentage of animals containing a full length translational fusion of gfp to myo-3 (myosin heavy chain A) where
tearing/collapse of arrayed sarcomeres was noted (five independent experiments, n=100). Below the graph is an example of an untreated animal
displaying tearing and collapse as well as an RNAi treated animal displaying a disorganisation of arrayed of sarcomeres (for comparison see normal,
disorganisation, tearing, and collapse in Figure 3 and Figure S1). *, **Significant difference from untreated (P,0.01, P,0.001) B) Displayed are the
percentage of animals containing mitochondrial and nuclear localized GFP where major fragmentation of the mitochondrial network was noted (five
independent experiments, n=100). Below the graph is an example of an untreated animal displaying major fragmentation of the mitochondrial
network and no visible nucleus as well as an RNAi treated animal displaying moderate fragmentation of the mitochondrial network and a GFP
expressing nucleus (for comparison see networked and moderate and severe fragmentation in Figure 4 and Figure S2). **Significant difference from
untreated (P,0.001). C) Displayed are the percentage of animals containing unc-112
+::GFP where tearing/collapse of arrayed attachment complexes
was noted (three independent experiments, n=60). Below the graph is an example of an untreated animal displaying normal arraying of attachment
complexes as well as an RNAi treated animal displaying collapse of arrayed complexes into a ball and also a dim-1(ra102) RNAi treated animals
displaying disorganisation of arrayed attachment complexes (for comparison see normal, disorganisation, and collapse in Figure S3). **Significant
difference from all other conditions (P,0.001). D) Displayed are the percentage of animals containing unc-95::GFP where tearing/collapse of arrayed
attachment complexes was noted (five independent experiments, n=100). Below the graph is an example of an untreated animal displaying normal
arraying of attachment complexes as well as an RNAi treated animal displaying collapse of arrayed complexes into a ball and also a dim-1 RNAi
treated animals displaying disorganisation of arrayed attachment complexes (for comparison see normal, disorganisation, and collapse in Figure S3).
**Significant difference between pat-2 RNAi treated wt versus all other conditions (P,0.001). All significance values are from two way repeated
measures ANOVA. Scale bars represent 15 mm.
doi:10.1371/journal.pgen.1002471.g006
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suppression when unc-112
ts mutants were treated with RNAi
against clp-1 and clp-7, clp-6 and clp-7,o rclp-1 and clp-6 (not
shown). Our results appear to support past in vitro findings that
calpain activity is important for the remodelling of integrin
containing focal adhesion complexes [60], and speculation that
calpains 1 [60], 2 [60] and 3 [61–64] may serve a similar function
in muscle, in vivo. It may be that multiple calpains participate in the
maintenance of integrin containing attachment complexes in
metazoan muscle.
Calpains have a role in maintenance of muscle
Given that calpains are activated in response to attachment
complex disruption, we tested if calpains are important for
maintenance of muscle attachment complexes. We acutely treated
fully developed, wild-type adult animals with RNAi against the clp
Figure 7. Calpain inhibition blocks protein degradation induced by acute loss of attachment. A) Age synchronised L1 stage unc-112
ts
mutants were gown to young adulthood at 16uC (t=0 h) before being temperature shifted to 25uC and cultured for a further 72 h under normal
conditions (top row), or on plates seeded with bacteria plus proteasome pathway inhibitors (+Lev, second row; +ZLLL, third row) or a lysosome
pathway inhibitor (+SB202190, fourth row). B) ced-3 (caspase 3) mutants were age synchronised at the L1 stage and grown to adulthood at 20uC
(t=0 h) before being cultured on RNAi plates against unc-97 or unc-112 for a further 72 h. In both A and B, at t=0 h and 72 h approximately 20–30
animals were stained for b-galactosidase activity (blue). C) unc-52
ts and D) unc-112
ts mutants were cultured for two generations at 16uC (permissive,
mutation inactive) under either normal, control conditions or on RNAi against clp-1, clp-4, tra-3, clp-6 or clp-7. Second generation animals were then
age synchronised at L1 stage and grown to young adulthood at 16uC (t=0 h) before being temperature shifted to 25uC (non-permissive, mutation
active) and cultured on the respective condition for a further 72 h. Some temperature shifted animals were also placed on calpain inhibitor II or
calpain inhibitor III drug plates (5 mg/ml) at t=0 h and cultured on drug plates for a further 72 h. Approximately 20–30 animals were stained for b-
galactosidase (blue) at t=0 h, and at 24 h, 48 h (not shown) and 72 h. All experiments were performed at least three times. The blue stain that
appears as circles in the centre of t=72 h animals is stain in muscles of developing embryos (for example unc-112
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complex disruption and assessed the same sub-cellular structural
phenotypes as previously assessed for the core complex members.
As shown in Figure 8 and Figure S5, RNAi against any of the
calpain genes tested resulted in defects within adult muscle.
However, as was the case for all other genes tested in this work, the
results were variable with respect to reproducibility and severity.
Using the same classification systems as above, we find the
following significant requirements for calpains in adult C. elegans
muscle: CLP-1, TRA-3, CLP-6, and CLP-7 appear to be required
to maintain arrayed sarcomeres; CLP-1, CLP-4, TRA-3, CLP-6
and CLP-7 appear to be required to prevent mitochondrial
fragmentation/disorganisation (RNAi against clp-4, tra-3, and clp-7
results in mitochondrial disorganisation, P,0.001 two way
repeated measures ANOVA, not shown); and CLP-4 appears to
be required to maintain arrayed attachment complexes. These
observations further suggest that calpains are important to
maintenance of adult muscle. As calpains appear to be needed
for proper maintenance of integrin attachments and as integrin
complex disruption results in activation of calpain mediated
degradation, these results suggest that calpains serve a similar role
in maintaining integrin attachment complexes in C. elegans muscle
as the one they serve in maintaining focal adhesion complexes in
cultured cells [60]. As C. elegans muscle lacks satellite cells, these
results suggest a cell intrinsic role for calpains in muscle
maintenance.
In cultured cells, members of the attachment complex itself are
targets of calpain degradation. We therefore tested if this also
appeared to be the case following calpain activation in C. elegans
muscle. As shown in Figure 8D, DEB-1/Vinculin is degraded in
unc-112
ts mutants following temperature upshift and this degra-
dation is not observed in unc-112
ts mutants treated with calpain
inhibitor II nor in unc-112
ts; dim-1 double mutants. It is unclear
whether DEB-1 degradation is cause or effect of complex
disassembly, and whether the degraded DEB-1 was in attachment
complexes, in a soluble precursor pool, or both. In any case, this
observation further supports the notion that calpains are
activated in response to attachment complex disruption in order
to facilitate attachment complex repair, and suggests that
attachment complex disruption normally occurs in vivo in C.
elegans muscle.
Calpains have a role in development of muscle
Our finding that calpains serve to maintain muscle attachment
complexes and the fact that mutations in calpain 3 cause Limb
Girdle Muscular Dystrophy 2A [63], prompted us to ask if the
calpains also have a role in proper development of muscle. To
test this, we used RNAi to knock down the identified calpain
genes over two generations and examined such chronically
treated adults for the same sub-muscular phenotypes as assessed
in acutely treated adults. Worms developed chronically on RNAi
against clp-1, clp-4, tra-3, clp-6 or clp-7 displayed disorganised
myofibrillar, mitochondrial, and muscle attachment complex
structures (Figure S6). Quantification of these defects (Figure 9)
suggests a significant requirement for CLP-1 and CLP-7 for
proper sarcomere development, CLP-1, CLP-4, TRA-3 and
CLP-6 for proper mitochondrial development, and CLP-1 for
proper integrin attachment complex formation. These results
suggest that each of these calpain genes has a role in normal
muscle development. Future study of animals with mutations in
each of these genes may allow further dissection of specific and
general requirements for calpains in C. elegans muscle develop-
ment and physiology.
Discussion
Why is synthesis of integrin attachment complex
proteins continuously required in terminally
differentiated, adult muscle?
The integrin attachment complexes of the C. elegans body wall
muscles serve three overlapping but partially distinct functions.
First, they anchor the ends of filaments of the contractile
apparatus, actin at the Z-line and myosin at the M-line, to enable
proper sarcomere assembly [30,31]. Second, they anchor body
wall muscles to basement membrane just as mammalian
costameres do. As hypodermal cells are also linked to the same
basement membrane [30], this provides a mechanism for muscle-
hypodermis communication and enables the contractile force of
the muscles to be transmitted to the exoskeleton (cuticle). Third,
they anchor body-wall muscles to each other. Since each
longitudinal body-wall muscle band is two cells wide, both
longitudinal and lateral attachments (attachment plaques) are
made between muscle cells [65,66]. These enable coordination
between adjacent muscles and are thought to be akin to
mammalian myotendinous junctions [67]. In metazoan muscle,
it is often assumed that integrin attachment complexes must be
stable in location and rigid in structure [60,68,69] to facilitate
similar intertwined functions. However, it is not completely clear
whether we should view the C. elegans muscle-hypodermis or
muscle-muscle attachments as inert or perhaps even as stable. A
worm increases about fourfold in length (250 mm to 1 mm) in
growing from a first-stage larva (L1) to reproductive adulthood
[70], and another 40% (to ,1.4 mm) before growth stops.
Increase in body width is approximately proportional and only 10
(of 95 total) new body-wall muscle cells are added postembryon-
ically [71,72]. Thus, for mobility to be maintained over this scale
of growth, the muscle and hypodermal tissues must grow in a well-
coordinated manner, primarily by hypertrophy rather than by
proliferation. Despite the existence of careful studies of sarcomere
assembly during embryonic development [30,72], we do not yet
know much about whether and how the attachment complexes
undergo dynamic changes to accommodate postembryonic
growth.
Here we have shown that genetic disruption of integrin
containing muscle attachment complexes, by temperature-sensi-
tive mutation or acute RNAi knockdown, results in general
degradation of proteins in muscle cytosol, disruption of sarcomere
organisation, fragmentation of mitochondria, and impairment of
mobility. These defects occur when gene products are knocked
down in fully developed, adult, muscle, so these results imply that
integrin containing attachment complexes are required for
maintenance of muscle. Additionally, as C. elegans muscle lacks
satellite cells these results demonstrate that it is the attachment
complexes within adult muscle cells that are required for
maintenance of adult muscle. One of the most striking aspects of
our findings is that these phenotypes can be induced in adults by
acute RNAi knockdown. In such experiments, normal attachment
complexes are present at the start of the RNAi treatment and
RNAi can only lower the abundance of functionally normal
proteins. We also observed that a set of phenotypes similar to those
induced by adult-onset RNAi could be induced when tempera-
ture-sensitive mutants (affected in either the extramuscular ligand
UNC-52 or the intramuscular attachment complex protein UNC-
112) were raised to adulthood at permissive temperature, and then
shifted to nonpermissive temperature. These mutants are not fully
normal even when grown at nonpermissive temperature, yet the
phenotypes become markedly more severe when the temperature
is raised. Taken together, these observations imply that the
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structures. Consistent with this, a recent study has shown that
some proteins associated with C. elegans sarcomeres do display
dynamic exchange in vivo [73]. Our examination of animals
labelled with an UNC-95::GFP fusion, which does display
dynamic exchange [73], suggests that as the adult animals grow,
the number of Z-line attachment complexes remains constant or
increases only slightly, while the spacing between adjacent
complexes increases to accommodate body growth (e.g. the Z-
line to M-line distance is the same but the Z-line to adjacent Z-line
distance is increased). This observation is in line with past
observations that the number of sarcomeres remains constant after
the last larval stage [30]. Both observations are most consistent
with a model in which each Z-line attachment complex as an
entity is maintained over time, but undergoes continuous dynamic
exchange and/or accretion of some constituent proteins to
accommodate animal growth. In the case of UNC-95, the data
suggest that it undergoes dynamic exchange [73] and also
accretion (as evidenced by the growing area of UNC-95::GFP
labelled Z-line complexes (Figure S4)). Thus, strong effects on
phenotype might be produced if RNAi depleted the free pool of
such an attachment complex protein so as to compromise either
exchange or accretion. Additionally, one might predict that the
increased distance between adjacent Z-line attachment complexes
would alter the tension on each Z-line attachment complex; this
has previously been suggested [74,75] and is postulated to increase
roughly linearly with postembryonic growth [43]. Continuing
protein accretion may make the attachment complexes more
robust to withstand this additional tension.
Figure 8. Calpains are important for maintenance of adult
C. elegans muscle. A) Animals expressing a full length translational
fusion of gfp to myo-3 (myosin heavy chain A) were age synchronised at
L1 stage and grown to young adulthood at 16uC (t=0 h). Adult animals
were then transferred to NGM RNAi plates [87] seeded with bacteria
expressing dsRNA against genes indicated for a further 72 h to mid-
adulthood. 20 random animals were picked and scored for identical
defects in sarcomere structure in at least two muscles within the animal
and this was repeated for 5 independent RNAi treatments (n=100
animals per condition/time point). Displayed is the percentage of
animals where torn or collapsed arrays of sarcomeres were observed
(average 6 SEM). Example images for each treatment can be found in
Figure S5. **Significant difference from control (t=72 h, (P,0.001)). B)
Animals expressing GFP labelled mitochondria and nuclei were grown,
treated and analysed as in A with the exception that mitochondrial
structure was scored. Displayed is the percentage of animals where
moderate fragmentation of the mitochondrial network was observed
(average 6 SEM). Example images for each treatment can be found in
Figure S5. *, **Significant difference from control (t=72 h, (P,0.01,
P,0.001)). C) Animals expressing GFP labelled attachment complexes
(UNC-95::GFP) were grown, treated and analysed as in A with the
exception that attachment complex structure was scored. Displayed is
the percentage of animals where torn or collapsed arrays of sarcomeres
were observed were observed (average 6 SEM). Example images for
each treatment can be found in Figure S5. **Significant difference from
control (t=72 h, (P,0.001)). D) Wild-type, unc-112
ts, and unc-112
ts; dim-
1(gk54) were age synchronised at L1 stage and grown to young
adulthood at 16uC (t=0 h). Adult animals were then transferred to 25uC
and grown for a further 72 h to mid-adulthood. Some unc-112
ts animals
were also placed on calpain inhibitor II drug plates (5 mg/ml) at t=0 h
and cultured on drug plates for a further 72 h. 30 animals were picked
for western blot analysis of DEB-1 levels at t=0 h, and at 72 h. All
experiments were performed at least three times. Displayed are
representative western blots for each condition and a graph of the
initial DEB-1 remaining at 72 h (average 6 SEM for three independent
experiments). **Significant difference from all other conditions
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attachment complexes?
The mechanism of mechanical coupling between adjacent Z-
lines in C. elegans is currently unknown. DIM-1 is localized around
the Z-line attachment complexes, so it is possible that DIM-1 is
required to allow for mechanical coupling between adjacent Z-
lines. The fact that normal arrays of Z and M-lines and of
sarcomeres are not typically seen in the absence of DIM-1
suggests decreased mechanical coupling must occur. Loss of dim-1
suppresses the protein degradation, collapse of arrayed sarco-
meres and attachment complexes, fragmentation of mitochon-
dria, and movement defects we observed in response to integrin
attachment complex disruption. The suppression of these
phenotypes by mutation in or RNAi targeting dim-1 suggests,
but does not prove, that it is additional mechanical strain placed
upon the integrin attachment complexes that causes them to fail
in response to acute gene knockdown of protein complex
members. Failure of attachment complexes through a combina-
tion of decreased gene function and mechanical strain has been
observed in animals with embryonic lethal mutations in members
of this complex [45]. In these worms, mechanical strain in the
form of onset of muscular contraction is known to be the cause of
failure of integrin attachment complexes. Though the precise
molecular composition and functions of these complexes are
different in embryos and adults, the consequences of failure are
strikingly similar, inasmuch as the micrographs of myosin in these
embryonic mutants look very much like the MYO-3::GFP
‘‘balling’’ phenotype we observed in response to some acute
RNAi knockdowns. Clearly, further work on dim-1 is required to
fully understand how dim-1 mutants suppress the pathologies
observed in response to genetic disruption of integrin attachment
complexes in adult muscle.
Why are calpains activated in response to integrin
complex disruption?
Whereas mutations in or RNAi against dim-1 suppress all of the
pathologies observed in response to genetic disruption of the
integrin attachment complexes, RNAi against genes encoding
calpains, or treatment with calpain inhibitors, suppresses the
degradation of cytosolic proteins but not the movement defect. By
contrast proteasome inhibitors, autophagy inhibitors, or a caspase
mutation fail to block the degradation. These data suggest that
calpains are activated in response to integrin attachment complex
disruption. The data show that calpains are necessary for the
degradation observed in response to genetic disruption of integrin
attachment complexes in fully developed muscle, but do not show
if calpain activation is sufficient.
Calpains are normally ascribed a role in partial rather than
complete degradation of proteins [76]. For example, partial
degradation of integrin attachment complex member proteins by
calpains is believed to have a role in both assembly and
disassembly of these complexes [60]. The calpain activation we
infer could be solely responsible for the degradation of cytosolic
protein as the result of catastrophic failure of the attachment
complexes (e.g. inability to reassemble/repair the complexes); this
is the simplest explanation. However, it is also possible that the
calpain activation could be required to signal increased degrada-
tion via another or a combination of other proteolytic systems. For
example, calpains (CLP-1 and TRA-3) and lysosomal proteases
(ASP-3 and ASP-4) are required sequentially in C. elegans neurons
undergoing excitotoxic cell death [57]. In the present study, RNAi
against single calpain genes clp-1, clp-4, tra-3, clp-6,o rclp-7 is
sufficient to suppress degradation. Thus, any potential sequential
activation of proteases in response to genetic disruption of integrin
attachment complexes is at least partially distinct from the
sequential activation observed in excitotoxic cell death in C.
elegans neurons. Whether or not calpain activation is solely
responsible for general degradation of cytosolic protein in response
to genetic disruption of integrin attachment complexes, the fact
that calpain activation is known to promote remodelling of such
attachment complexes [60] suggests that this is the reason for
initial activation of the calpains. Consistent with calpains serving
to maintain integrin attachment complexes in adult muscle, we
Figure 9. Calpains are important for development of C. elegans
muscle. Wild-type animals expressing a full length translational fusion
of gfp to myo-3 (myosin heavy chain A), GFP labelled mitochondria and
nuclei, or GFP labelled attachment complexes (UNC-95::GFP) were
cultured from L4 stage to young adulthood under normal conditions at
20uC and on RNAi targeting clp-1, clp-4, tra-3, clp-6 or clp-7. 20 random
animals were scored for identical sub-cellular defects in at least two
muscles at adulthood and 24 and 48 h post-adulthood in both the F1
and F2 generations (e.g. n=120 per condition). A) Percentage of
animals with normally arrayed sarcomeres (average 6 SEM). Example
images for each treatment can be found in Figure S6. *, **Significant
difference from control (P,0.01, P,0.001). B) Percentage of animals
with networked mitochondria (average 6 SEM). Example images for
each treatment can be found in Figure S6. *Significant difference from
control (P,0.01). C) Percentage of animals with arrayed attachment
complexes (average 6 SEM). Example images for each treatment can be
found in Figure S6. *Significant difference from control (P,0.01). All
significance values are from one way ANOVA.
doi:10.1371/journal.pgen.1002471.g009
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against the calpains results in attachment complex disruption,
defects in the normal arraying of sarcomeres, and mitochondrial
fragmentation. Additionally, we found that calpains do degrade
the attachment complex member DEB-1/Vinculin when the
complex is disrupted. Thus, in adult C. elegans muscles, integrin
attachment complexes and calpains appear to participate in a
feedback system whereby integrin attachment complex disruption
can activate calpains and calpain activation facilitates repair/
remodelling of disrupted complexes. This system allows these
complexes to carry out their intertwined functions, including
coordinated growth. In support of this suggestion, one of the
calpain genes that participates in this system, tra-3, was recently
shown to be mutated in a natural variant strain that fails to alter
growth in response to temperature [77]. More work is required to
understand the specific roles these calpains serve in vivo and also
the interrelationship(s) between them.
What is causing the decline in movement in response to
attachment complex disruption?
While it is tempting to suggest that the cytosolic degradation,
sarcomere disorganisation, or mitochondrial fragmentation is
causing the movement decline we observe, each individual defect
has previously been shown to be sufficient to cause a movement
decline [20,78–80]. Thus, which particular subcellular damage(s)
leads to the organismal level mobility defect may be somewhat
specific to each RNAi treatment, and each may in fact be the
result of quantitatively different effects in multiple subcellular
compartments within different individuals receiving the same
RNAi treatment. For example, given the extent of intra-
muscular pathology observed in response to RNAi against a
core complex component, a very severe movement decline is
entirely expected if each defect is sufficient to cause a movement
decline and each effect is additive. Similarly, it is not particularly
surprising that when both the sarcomeres and mitochondria
show defects, the movement decline is significantly greater in
animals with more severe mitochondrial disruption (for example
tln-1). Conversely, it may be somewhat surprising that RNAi
against cdc-42 produces a severe movement decline, as it does not
produce similar severities of sub-cellular pathologies (as the core
complex and tln-1) and also quite surprising that RNAi against
unc-89 produces only a modest decline in movement despite
producing highly disorganised arrays of sarcomeres and
attachment complexes and substantial fragmentation of mito-
chondria. Thus, while a clear relationship exists for the core
complex as a group, the more peripheral components of the
complex appear to have more individual differences, perhaps as
the result of more specialized functions of each gene product.
Future prospective studies of individual animals where defects in
multiple sub-muscular compartments are followed in parallel
with movement decline may shed further light on this question,
as may further studies of genes for which RNAi treatments
produce unique patterns of sub-cellular defects (for example unc-
89). Additionally, as different components of these attachment
complexes have been shown to have different kinetics of
exchange within these complexes [73], it could prove quite
interesting to conduct studies which attempt to correlate the
relative severity of movement defect and/or subcellular pathol-
ogy with the kinetics of exchange. Regardless of the complexity,
it seems clear that loss of integrin attachment complexes in adult
muscle has multiple subcellular consequences, which usually
result in decline in movement that is related to the extent of
intramuscular damage.
How is the general degradation seen in response to
integrin complex disruption relevant to human health
and/or disease?
We started these studies because two members of an integrin
attachment complex showed decreased mRNA expression in
response to spaceflight [22], a condition associated with disuse
atrophy, and because RNAi targeting these genes provoked
general protein degradation within muscle [29]. Here we have
shown that acute genetic disruption of the core members of muscle
integrin attachment complexes results in activation of calpains,
and we have argued that the main physiologic role of this
activation is to facilitate repair and/or replacement of damaged
complexes. It should prove a matter of much interest to determine
if attachment complex disruption occurs in higher animals and if
calpains serve a similar muscle intrinsic repair/remodelling role. It
may be that the Z-line streaming observed in human muscle
subjected to prolonged physical forces [81] is a hint that these
complexes can be damaged and repaired in higher animals. If
calpains serve such a role in higher animals, then it is almost
certainly the case that the general degradation seen in response to
integrin complex disruption is transient and thus the main role of
this degradation is in facilitating repair/remodelling, not in
causing muscle atrophy. However, it is likely that in conditions
of prolonged disruption of these attachment complexes, calpain
activation and the consequent general degradation would be
sustained. It may be the case that the general degradation we
observe is relevant to muscle wasting seen in the congenital
myopathy in individuals with a mutation in an integrin receptor
gene [82]. Additionally, our results add support to the notion that
lack of calpain activity accounts for part of the progressive
dystrophy noted in rodent calpain mutants [62] and in humans
suffering calpain mutations [63].
Moving toward an integrated picture of the control of
muscle protein degradation in vivo
Here we have reported that genetic disruption of integrin based
attachment to the basement membrane induces calpain activation
and subsequent general degradation of cytosolic protein content.
This is the fourth cell surface receptor on C. elegans muscle
identified as a regulator of proteolysis and the third intramuscular
proteolytic system shown to be regulated by extramuscular signals
[18–20]. Thus, we are moving closer to an integrated picture of
how C. elegans muscle co-ordinately maintains cytosolic protein
content in response to external cues. All signals identified to date
have human orthologs [83], suggesting that some knowledge of
integrated control of human muscle protein content can be
gleaned from C. elegans.
Materials and Methods
Nematode growth, genetics, and transgenics
Nematode strains were maintained and grown using standard C.
elegans culturing techniques [84] at 20uC or, in the case of
temperature sensitive mutants at 16uC, using the Escherichia coli
strain OP50 as food source. Genetic constructions were conducted
using standard techniques. Mutant alleles used in this work were as
follows: LG I: mek-2(ku114); LG II: unc-52(e669su250
ts); clr-
1(e1475
ts); LG III: daf-2(m41





LG X: dim-1 (gk54) and (ra102). The transgenes used in these
experiments were as follows: ccIs55 (sup-7(st5); unc-54::lacZ;
integrated on LG V) for assessing protein degradation with
histology as previously described [17]; jIs01 (rol-6(su1006); myo-
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with fluorescent microscopy [38], ccIs4251 (pSAK4 (myo-3
promoter driving mitochondrially targeted GFP); pSAK2 (myo-3
promoter driving a nuclear-targeted GFP::LacZ fusion); and a dpy-
20 subclone; integrated on LG I) [85] and zcIs14 (myo-3::GFP
mt;
unknown site of integration) [86] for visualising the mitochondria
with fluorescent microscopy; ryIs22 (rol-6(su1006); unc-95::GFP;
integrated on LG X) [55] and raEx16 (rol-6(su1006); unc-112
+::GFP)
[24] for visualising the muscle attachment complexes with
fluorescent microscopy, these encode GFP tagged UNC-95 and
UNC-112 respectively; and dvIs511 (pCL197(Pmyo-3::Ub-G76V-
GFP); pCL148(Pmyo-3::DsRed monomer); integrated on LG I) (gift
from Chris Link, University of Colorado at Boulder), and njEX38
(pGo::GFP, rol-6(su1006), punc-54::daf-2
+) [20] for visualising any loss
of cytosolic protein due to membrane disruption, these include
DsRed and GFP constructs expressed in the body wall muscle
cytosol. raEx16 was also used in the unc-112
ts rescue experiments.
Development of animals on RNAi
Culturingwasessentiallyasdescribed[87].Forchronictreatment
with RNAi four L4 larvae were transferred to standard RNAi plates
with bacterial lawns expressing double-stranded RNA for the
relevant genes. Most bacterial lawns expressing double-stranded
RNA were grown from bacterial clones from the MRC Ahringer
Library [87]. Bioinformatic work was conducted utilizing Worm-
Base [88]. MRC clones used were as follows: atn-1: V-8I08, cdc-42:
II-5P13, Y71G12B.11: I-8K21, pat-2: III-4P15; pat-4: III-1C19; pat-
6: IV-1E21; uig-1: V-8D12; unc-52: II-9A20; unc-89: I-1B22; unc-97:
X-3I11; unc-112: V-9L03; zyx-1: II-8H13; clp-1: III-4O15; tra-3:I V -
7D13; clp-6: IV-1D01; clp-7: IV-1B23; mek-2: I-7L20; mpk-1:I I I -
2I01. Bacterial lawns expressing double-stranded RNA targeting
clp-4 or deb-1 were, respectively, grown from a bacterial clone which
was kindly provided by Chris Link (University of Colorado at
Boulder) or from a clone from the Open Biosystems Vidal Library
[89], clone 10002-B11. Bacterial lawns expressing double-stranded
RNA targeting pat-3 were grown from a bacterial clone produced
for this work. Briefly, an L4440 plasmid containing an ,1.8 kB
cDNA fragment of pat-3 (BamHI digestion product from a Yuji
Kohara cDNA clone, provided by Hiroshi Qadota (Emory
University)) was transfected into HT115 (DlacZ, produced by
mutagenesis) and confirmed as described [87]. Behavioural,
developmental, and sub-cellular phenotypes were scored in the F1
and F2 generations as described [29]. Sub-cellular phenotypes were
scored as described above at early adulthood and 24, 48, and
72 hours later. In experiments where RNAi against a gene was
tested for ability to suppress degradation or subcellular pathology
(e.g. mpk-1, mek-2, clps,a n ddim-1 in unc-112
ts or unc-52
ts mutants or
inwt),strainsweregrown on RNAi foratleasttwogenerations prior
to the onsetofacutetemperatureshiftexperiments(e.g.experiments
were always conducted in F3 or later generations).
Acute treatment of adult animals with RNAi
Animals were roughly age-synchronised as described [17].
Animals were then re-plated to fresh OP50 bacterial lawns and
grown at 16uC for 48–60 hours to early adulthood. Subsequently,
animals were manually transferred to standard RNAi plates seeded
with standard E. coli HT115 RNAi feeding vector(s) [87], as
described above. Transgenic animals were analysed for protein
degradation, sarcomere defects, mitochondrial defects, or attach-
mentcomplexabnormalitiesat24,48and 72 hourspost-adulthood.
Microscopy
All images were captured on either a Leitz Orthoplan with
Leica DFC300F digital camera and Leica Firecam software
(Pittsburgh), a Nikon H600L with a Nikon Digital Sight DS-Fi1
digital camera and proprietary software (Nottingham), or a Zeiss
AX10 with an Axiocam MRC digital camera and Axiovision LE
software (Nottingham). Confocal images (Pittsburgh) were ob-
tained on Leica TCS-SP5 or Olympus FV1000 microscopes and
analysed with ImageJ software. Other image analysis and figure
preparation was conducted in Photoshop. RITC-phalloidin was
used as previously described [37].
Acute activation of temperature-sensitive mutant
animals
Animals were roughly age-synchronised as described [17].
Animals were then re-plated to fresh OP50 bacterial lawns or fresh
RNAi clone lawns and grown at 16uC for 48–60 h to early
adulthood. Subsequently, animals were transferred to 25uC; in the
case of drug experiments animals were placed on either OP50 or
drug plates immediately prior to temperature upshift. Transgenic
animals were analysed for protein degradation, sarcomere defects,
mitochondrial defects, or movement defects at 24, 48 and 72 h
post-adulthood.
Immunoblotting
Western blots in Pittsburgh were conducted as previously
described [19,20,37,38] utilizing the following primary antibodies:
anti-b-galactosidase JIE7, anti-myosin heavy-chain A 5–14, and
anti-actin JLA20 [90], all from Developmental Studies Hybridoma
Bank, University of Iowa, USA; and anti-pTpY-ERK 9101S from
Cell Signalling Technologies. Peroxidase-conjugated donkey anti-
mouse and donkey anti-rabbit secondary antibodies were from
Jackson Immunoresearch. For analysis of myosin and actin
degradation in unc-112
ts mutants, blots were probed for both b-
galactosidase and actin or myosin so that a direct comparison of
degradation could be made.
Western blots in Nottingham were conducted as follows: 30
worms were picked into 13 ml M9 Buffer and 7 ml3 6Laemmli
buffer was added prior to boiling for 5 min. Lysates were then
frozen at 220uC until analysis. Subsequently, samples were
thawed on ice, vortexed thoroughly and loaded onto precast 18-
well 12% sodium dodecyl sulfate polyacrylamide electrophoresis
gels (Criterion XT Bis-Tris; Bio-Rad, Hemel Hempstead, UK)
and run at 200 V for 1 h. After equilibration in transfer buffer for
15 min, the gel was transferred on ice at 100 V for 45 min to a
methanol pre-wetted 0.2 mm Immobilon PVDF membrane
(Millipore). Next, the membrane was blocked in 5% (w/v) BSA
in TBS-T (Tris Buffered Saline and 0.1% Tween-20) for 1 h at
room temperature and then incubated overnight at 4uCi n
primary b-galactosidase antibody (Promega) or DEB-1 antibody
([91], Developmental Studies Hybridoma Bank) at a 1:40,000
dilution or 1:1,000 (respectively) in 5% (w/v) BSA in TBS-T. The
following morning the membrane was washed (365 min) in TBS-
T and then incubated in peroxidase-conjugated donkey anti-
mouse secondary antibody (R&D systems) at a 1:16,000 dilution in
5% BSA/TBS-T for 1 hour at room temperature. After further
washes (365 min) in TBS-T the membrane was developed using
Immunstar ECL reagent (Bio-Rad) for 5 min and the protein
bands visualised on a Chemidoc XRS system (Bio-Rad). Peak
densities of the bands were statistically analysed by two-way
repeated measures ANOVA using GraphPad Prism 5.
Use and confirmation of in vivo activity of pharmacologic
agents
Cycloheximide (CHx) was used as previously described on 5 ml
plates [17]. Confirmation that the cycloheximide was active was
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generation. Levamisole (Lev) and MG132 (ZLLL) were used as
previously described on 5 ml plates [17,18]. Confirmation that
levamisole and MG132 were active was achieved by noting block
of degradation in cha-1
ts animals at 34 hours post temperature
upshift. SB201290 was used as previously described on 5 ml plates
[20]. Confirmation that SB201290 was active was achieved by
noting block of degradation in clr-1
ts or let-60
ts animals at 48 or
72 hours post temperature upshift, respectively. N6, N6-dimethy-
ladenosine (Toronto Research Chemicals) was used at 0.5 mM.
Confirmation that N6, N6-dimethyladenosine was active was
achieved by noting block of degradation in daf-2
ts mutants at 48–
72 h after a shift to 25uC. Calpain inhibitors II and III
(BioChemica) were prepared as 5 mg/ml stock solutions in
DMSO. These stock solutions were added to the bacterial lawn
of seeded NGM plates as 1:1000 dilutions (typically 5 mlo na5m l
plates) and allowed to dry 1–3 days prior to use. Animals were
picked directly onto the location of seeding with the drug. DMSO
only vehicle control plates were prepared similarly.
Movement analysis
Movement analysis was conducted essentially as described
[19,20]. All experiments were conducted by a single individual to
prevent individual to individual differences in scores. For
Figure 2A (BF, Pittsburgh): Wild-type or unc-112
ts animals were
temperature shifted as indicated and movement assessed at the
indicated times. (unc-112
ts/+heterozygotes were generated by
crossing homozygous unc-112
ts hermaphrodites with mIs10 (Pmyo-
2::GFP; integrated on LG V) males and collecting F1 hermaph-
rodites with pharyngeal GFP). Five animals were picked and
assessed 10 times for a total of 50 independent measurements for
each genotype at each timepoint. For Figure 2B and 2C (TE,
Nottingham): Wild-type (ccIs55)o rdim-1(ra102) animals were
treated acutely with RNAi and rates of movement were assessed
at young adulthood (t=0 hour) and mid-adulthood (72 hours
post RNAi treatment) time points. Animals were individually
picked into 10 ml M9 buffer. The number of sinusoidal
movement patterns completed over 10 seconds was recorded
and multiplied to obtain movement rate per minute. This was
repeated 10 times for each animal to give a total of 100 measures
per experimental treatment. In the case of severe movement
defects where there was an absence of sinusoidal movements due
to paralysis, the number of times the head of the animal moved
from left-to-right and left again was measured. Movement data
were analysed for each strain by two-way repeated measures
ANOVA in GraphPad Prisim5.
Supporting Information
Figure S1 Acute loss of muscle attachment causes disorganisa-
tion and collapse of arrayed sarcomeres. Animals expressing a full
length translational fusion of gfp to myo-3 (myosin heavy chain A)
were age synchronised at L1 stage and grown to young adulthood
at 16uC (t=0 h). Adult animals were then transferred to NGM
RNAi plates [87] seeded with bacteria expressing dsRNA against
genes indicated for a further 72 h to mid-adulthood. Displayed are
sample images of defects in sarcomere structure observed for each
indicated treatment. White arrow, minor sarcomere disorganisa-
tion (Examples: atn-1, deb-1); yellow arrow, major sarcomere
disorganisation (Examples: unc-82, tln-1); red arrow, balled array of
sarcomeres (Example: unc-112), red asterisk, torn array of
sarcomeres (Example: unc-52). Scale bar represents 50 mm.
Quantification of defects can be found in Figure 3; note that
minor disorganisation (e.g. white arrows) was classed as normal for
the purposes of quantification, whereas major disorganisation (e.g.
yellow arrows) was classed as disorganised.
(TIF)
Figure S2 Acute loss of muscle attachment results in mitochon-
drial fragmentation. Animals expressing GFP-tagged mitochon-
dria and nuclei were age synchronised at L1 stage and grown to
young adulthood at 16uC (t=0 h). Animals were then transferred
to NGM RNAi plates [87] seeded with bacteria expressing dsRNA
against genes indicated for an additional 72 h (mid-adulthood) at
20uC. Examples of networked, disorganised, and moderately and
majorly fragmented mitochondria are displayed in Figure 4, where
quantification of these defects can also be found. Minor
fragmentation is usually classed as disorganised (for example the
t=72 h control image shows minor fragmentation on either side
of the nucleus). Scale bar represents 50 mm.
(TIF)
Figure S3 Acute genetic disruption of attachment complex
genes results in disorganisation and collapse of attachment
complexes. Animals expressing GFP-tagged attachment complexes
(UNC-95::GFP) were age synchronised at L1 stage and grown to
young adulthood at 16uC (t=0 h). Animals were then transferred
to NGM RNAi plates [87] seeded with bacteria expressing dsRNA
against genes indicated for an additional 72 h (mid-adulthood) at
20uC. The 20 most Unc animals were picked and scored for
identical defects in attachment complex structure in at least two
muscles within the animal and this was repeated for 5 independent
RNAi treatments (n=100 animals per condition/time point). A)
Percentage of animals where only normal arrays of attachment
complexes were observed is displayed as average 6 SEM. Below
the graph is an example of an RNAi treated animal displaying
normal arrays of attachment complexes (as indicated by straight
parallel lines of GFP), these are enlarged 300% to the right of the
micrograph. Note that Z-line attachment complexes, termed dense
bodies, appear as punctate lines (white arrow) while M-line
attachment complexes appear as a continuous line (yellow arrow).
B) Percentage of animals where disorganisation of arrayed
attachment complexes were observed is displayed as average 6
SEM. Below the graph is an example of an RNAi treated animal
displaying disorganised attachment complex arrays (as indicated
by lack of straight parallel lines of GFP), these are enlarged 300%
to the right of the micrograph. C) Percentage of animals where
sarcomere arrays have collapsed into ball like structures is
displayed as average 6 SEM. Below the graph is an example of
an RNAi treated animal displaying a collapsed array of sarcomeres
(as indicated by GFP that appear as circular lines rather than
straight lines, see also Figure 6C and 6D for examples), these are
enlarged 300% to the right of the micrograph. **Significant
difference from control t=72 h, P,0.001 (two way repeated
measures ANOVA). Scale bars represent 15 mm.
(TIF)
Figure S4 Z-line attachment complexes increase in area as C.
elegans grow larger post-adulthood. Live worms of a strain carrying
an unc-95::gfp fusion were examined by confocal microscopy at the
fourth larval stage (t=224 h, worm length=0.7560.02 mm), one
day later as young adults (t=0 h, length=1.0360.03 mm) or an
additional two days later (t=48 h, length=1.4460.02 mm).
Images (7–9 worms of each group) were taken of a muscle cell
in an approximately constant position (just posterior to the vulva,
inner or outer cell in a band), fragments of adjacent cells and the
M-lines removed manually in Photoshop, and the fluorescent Z-
line attachment complexes (dense bodies) counted and their sizes
measured using ImageJ software. The number of dense bodies per
cell was t=224 h, 333626; t=0 h, 412624; t=48 h, 402631;
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of dense bodies per cell changes. The arrows indicate the medians
of the dense body area distributions for t=224 h (median
area=0.23 mm
2, n=3002), t=0 h, young adults (med-
ian=0.35 mm
2, n=2888) or t=48 h (median=0.71 mm
2,
n=2813). In some rare instances, Image J fails to separate
adjacent bodies, leading to an artifactually high size measurement
(.1.5 mm
2, at right); this distorts means but has little effect on
medians. All pairwise comparisons show that differences between
these size distributions are highly significant (P,0.0001, 2-tailed
T-tests with unequal variances).
(TIF)
Figure S5 Calpains are important for maintenance of adult C.
elegans muscle. A) Animals expressing a full length translational
fusion of gfp to myo-3 (myosin heavy chain A) were age
synchronised at L1 stage and grown to young adulthood at
16uC (t=0 h). Adult animals were then transferred to NGM
RNAi plates [87] seeded with bacteria expressing dsRNA against
genes indicated for a further 72 h to mid-adulthood. B) Animals
expressing GFP labelled mitochondria and nuclei were grown and
treated as in A. C) Animals expressing GFP labelled attachment
complexes (UNC-95::GFP) were grown, treated and analysed as in
A. Quantification of defects can be found in Figure 8. Scale bars
represent 15 mm.
(TIF)
Figure S6 Calpains are important for development of C. elegans
muscle. A) Animals expressing a full length translational fusion of
gfp to myo-3 (myosin heavy chain A) were cultured from L4 stage to
young adulthood under normal conditions at 20uC and on RNAi
targeting clp-1, clp-4, tra-3, clp-6 or clp-7. B) Animals expressing
GFP labelled mitochondria and nuclei were grown and treated as
in A. C) Animals expressing GFP labelled attachment complexes
(UNC-95::GFP) were grown, treated and analysed as in A.




Dr. Chris Link graciously provided a RNAi feeding vector against clp-4 and
transgenic worms containing dvIs511. Dr. Limor Broday graciously
provided transgenic worms containing ryIs22.D r .D o nM o e r m a n
graciously provided transgenic worms containing raEx16. Dr. Hiroshi
Qadota graciously provided an L4440 plasmid containing an ,1.8 kb
BamHI digest of pat-3 cDNA.
Author Contributions
Conceived and designed the experiments: TE EAO SL BDF LAJ NJS.
Performed the experiments: TE EAO SL BDF FS LAJ NJS. Analyzed the
data: TE EAO SL BDF FS LAJ NJS. Wrote the paper: LAJ NJS. Made the
figures: SL FS NJS.
References
1. Febbraio MA, Pedersen BK (2005) Contraction-induced myokine production
and release: is skeletal muscle an endocrine organ? Exerc Sport Sci Rev 33:
114–119.
2. Hill AV, Hartree W (1920) The four phases of heat-production of muscle.
J Physiol 54: 84–128.
3. Huxley AF, Niedergerke R (1954) Structural changes in muscle during
contraction; interference microscopy of living muscle fibres. Nature 173:
971–973.
4. Spargo E, Pratt OE, Daniel PM (1979) Metabolic functions of skeletal muscles of
man, mammals, birds and fishes: a review. J R Soc Med 72: 921–925.
5. Clark KA, McElhinny AS, Beckerle MC, Gregorio CC (2002) Striated muscle
cytoarchitecture: an intricate web of form and function. Annu Rev Cell Dev Biol
18: 637–706.
6. Chance B, Leigh JS, Jr., Clark BJ, Maris J, Kent J, et al. (1985) Control of
oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-
state analysis of the work/energy cost transfer function. Proc Natl Acad Sci U S A
82: 8384–8388.
7. Tisdale MJ (2000) Protein Loss in Cancer Cachexia. Science 289: 2293–2294.
8. Landi F, Russo A, Liperoti R, Pahor M, Tosato M, et al. (2010) Midarm muscle
circumference, physical performance and mortality: Results from the aging and
longevity study in the Sirente geographic area (ilSIRENTE study). Clinical
Nutrition 29: 441–447.
9. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R (2004) The Healthcare
Costs of Sarcopenia in the United States. Journal of the American Geriatrics
Society 52: 80–85.
10. Yelin E (2003) Cost of musculoskeletal diseases: impact of work disability and
functional decline. The Journal of Rheumatology 68: 8–11.
11. Arrigo A-P, Tanaka K, Goldberg AL, Welch WJ (1988) Identity of the 19S
‘prosome’ particle with the large multifunctional protease complex of
mammalian cells (the proteasome). Nature 331: 192–194.
12. Hershko A, Ciechanover A, Rose IA (1979) Resolution of the ATP-dependent
proteolytic system from reticulocytes: a component that interacts with ATP. Proc
Natl Acad Sci U S A 76: 3107–3110.
13. Novikoff AB, Beaufay H, de Duve C (1956) ELECTRON MICROSCOPY OF
LYSOSOME-RICH FRACTIONS FROM RAT LIVER. The Journal of
Biophysical and Biochemical Cytology 2: 179–184.
14. Murachi T TK, Hatanaka M, Murakami T (1980) Intracellular Ca2+
-dependent protease (calpain) and its high-molecular-weight endogenous
inhibitor (calpastatin). Advances in Enzyme Regulation 19: 18.
15. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993) The C. elegans cell
death gene ced-3 encodes a protein similar to mammalian interleukin-1[beta]-
converting enzyme. Cell 75: 641–652.
16. Sandri M (2008) Signaling in Muscle Atrophy and Hypertrophy. Physiology 23:
160–170.
17. Zdinak LA, Greenberg IB, Szewczyk NJ, Barmada SJ, Cardamone-Rayner M,
et al. (1997) Transgene-coded chimeric proteins as reporters of intracellular
proteolysis: Starvation-induced catabolism of a lacZ fusion protein in muscle
cells of Caenorhabditis elegans. Journal of Cellular Biochemistry 67: 143–153.
18. Szewczyk N, Hartman J, Barmada S, Jacobson L (2000) Genetic defects in
acetylcholine signalling promote protein degradation in muscle cells of
Caenorhabditis elegans. J Cell Sci 113: 2003–2010.
19. Szewczyk NJ, Jacobson LA (2003) Activated EGL-15 FGF receptor promotes
protein degradation in muscles of Caenorhabditis elegans. EMBO J 22:
5058–5067.
20. Szewczyk NJ, Peterson BK, Barmada SJ, Parkinson LP, Jacobson LA (2007)
Opposed growth factor signals control protein degradation in muscles of
Caenorhabditis elegans. EMBO J 26: 935–943.
21. Bulow HE, Boulin T, Hobert O (2004) Differential functions of the C. elegans
FGF receptor in axon outgrowth and maintenance of axon position. Neuron 42:
367–374.
22. Higashibata A, Szewczyk NJ, Conley CA, Imamizo-Sato M, Higashitani A, et al.
(2006) Decreased expression of myogenic transcription factors and myosin heavy
chains in Caenorhabditis elegans muscles developed during spaceflight. J Exp
Biol 209: 3209–3218.
23. Hobert O, Moerman DG, Clark KA, Beckerle MC, Ruvkun G (1999) A
Conserved LIM Protein That Affects Muscular Adherens Junction Integrity and
Mechanosensory Function in Caenorhabditis elegans. The Journal of Cell
Biology 144: 45–57.
24. Rogalski TM, Mullen GP, Gilbert MM, Williams BD, Moerman DG (2000) The
UNC-112 Gene in Caenorhabditis elegansEncodes a Novel Component of Cell–
Matrix Adhesion Structures Required for Integrin Localization in the Muscle
Cell Membrane. The Journal of Cell Biology 150: 253–264.
25. Lee M, Cram EJ, Shen B, Schwarzbauer JE (2001) Roles for b(pat-3) Integrins in
Development and Function ofCaenorhabditis elegans Muscles and Gonads.
Journal of Biological Chemistry 276: 36404–36410.
26. Gordon SE, Flu ¨ck M, Booth FW (2001) Selected Contribution: Skeletal muscle
focal adhesion kinase, paxillin, and serum response factor are loading dependent.
Journal of Applied Physiology 90: 1174–1183.
27. Klossner S, Durieux A-C, Freyssenet D, Flueck M (2009) Mechano-transduction
to muscle protein synthesis is modulated by FAK. European Journal of Applied
Physiology 106: 389–398.
28. Lecroisey C, Se ´galat L, Gieseler K (2007) The C. elegans; dense body: anchoring
and signaling structure of the muscle. Journal of Muscle Research and Cell
Motility 28: 79–87.
29. Shephard F, Adenle AA, Jacobson LA, Szewczyk NJ (2011) Identification and
Functional Clustering of Genes Regulating Muscle Protein Degradation from
amongst the Known C. elegans Muscle Mutants. PLoS ONE 6: e24686.
doi:10.1371/journal.pone.0024686.
30. Moerman DG, Williams BD (2006) Sarcomere assembly in C. elegans muscle.
WormBook. pp 1–16.
31. Qadota H, Benian GM (2010) Molecular structure of sarcomere-to-membrane
attachment at M-Lines in C. elegans muscle. J Biomed Biotechnol 2010: 864749.
Calpain-Mediated Muscle Repair
PLoS Genetics | www.plosgenetics.org 18 January 2012 | Volume 8 | Issue 1 | e100247132. Warner A, Qadota H, Benian GM, Vogl AW, Moerman DG (2011) The
Caenorhabditis elegans paxillin orthologue, PXL-1, is required for pharyngeal
muscle contraction and for viability. Mol Biol Cell 22: 2551–2563.
33. Lecroisey C, Martin E, Mariol MC, Granger L, Schwab Y, et al. (2008) DYC-1,
a protein functionally linked to dystrophin in Caenorhabditis elegans is
associated with the dense body, where it interacts with the muscle LIM domain
protein ZYX-1. Mol Biol Cell 19: 785–796.
34. Hoppe PE, Chau J, Flanagan KA, Reedy AR, Schriefer LA (2010)
Caenorhabditis elegans unc-82 encodes a serine/threonine kinase important
for myosin filament organization in muscle during growth. Genetics 184: 79–90.
35. Benian GM, Tinley TL, Tang X, Borodovsky M (1996) The Caenorhabditis
elegans gene unc-89, required fpr muscle M-line assembly, encodes a giant
modular protein composed of Ig and signal transduction domains. J Cell Biol
132: 835–848.
36. Hikita T, Qadota H, Tsuboi D, Taya S, Moerman DG, et al. (2005)
Identification of a novel Cdc42 GEF that is localized to the PAT-3-mediated
adhesive structure. Biochemical and Biophysical Research Communications
335: 139–145.
37. Szewczyk NJ, Peterson BK, Jacobson LA (2002) Activation of Ras and the
Mitogen-Activated Protein Kinase Pathway Promotes Protein Degradation in
Muscle Cells of Caenorhabditis elegans. Mol Cell Biol 22: 4181–4188.
38. Fostel JL, Benner Coste L, Jacobson LA (2003) Degradation of transgene-coded
and endogenous proteins in the muscles of Caenorhabditis elegans. Biochemical
and Biophysical Research Communications 312: 173–177.
39. Benian GM, Tinley TL, Tang X, Borodovsky M (1996) The Caenorhabditis
elegans gene unc-89, required fpr muscle M-line assembly, encodes a giant
modular protein composed of Ig and signal transduction domains. The Journal
of Cell Biology 132: 835–848.
40. Rogalski TM, Williams BD, Mullen GP, Moerman DG (1993) Products of the
unc-52 gene in Caenorhabditis elegans are homologous to the core protein of the
mammalian basement membrane heparan sulfate proteoglycan. Genes Dev 7:
1471–1484.
41. Rogalski TM, Gilbert MM, Devenport D, Norman KR, Moerman DG (2003)
DIM-1, a Novel Immunoglobulin Superfamily Protein in Caenorhabditis
elegans, Is Necessary for Maintaining Bodywall Muscle Integrity. Genetics
163: 905–915.
42. Otey CA, Rachlin A, Moza M, Arneman D, Carpen O (2005) The palladin/
myotilin/myopalladin family of actin-associated scaffolds. Int Rev Cytol 246:
31–58.
43. Plenefisch JD, Zhu X, Hedgecock EM (2000) Fragile skeletal muscle attachments
in dystrophic mutants of Caenorhabditis elegans: isolation and characterization
of the mua genes. Development 127: 1197–1207.
44. Mariol MC, Martin E, Chambonnier L, Segalat L (2007) Dystrophin-dependent
muscle degeneration requires a fully functional contractile machinery to occur in
C. elegans. Neuromuscul Disord 17: 56–60.
45. Williams BD, Waterston RH (1994) Genes critical for muscle development and
function in Caenorhabditis elegans identified through lethal mutations. J Cell
Biol 124: 475–490.
46. Meissner B, Warner A, Wong K, Dube N, Lorch A, et al. (2009) An Integrated
Strategy to Study Muscle Development and Myofilament Structure in
Caenorhabditis elegans. PLoS Genet 5: e1000537. doi:10.1371/journal.pgen.
1000537.
47. Norman KR, Cordes S, Qadota H, Rahmani P, Moerman DG (2007) UNC-97/
PINCH is involved in the assembly of integrin cell adhesion complexes in
Caenorhabditis elegans body wall muscle. Developmental Biology 309: 45–55.
48. Perkins AD, Ellis SJ, Asghari P, Shamsian A, Moore EDW, et al. (2010) Integrin-
mediated adhesion maintains sarcomeric integrity. Developmental Biology 338:
15–27.
49. Koh TJ, Escobedo J (2004) Cytoskeletal disruption and small heat shock protein
translocation immediately after lengthening contractions. Am J Physiol Cell
Physiol 286: C713–722.
50. Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, et al. (2005) The kinase
domain of titin controls muscle gene expression and protein turnover. Science
308: 1599–1603.
51. Ichishita R, Tanaka K, Sugiura Y, Sayano T, Mihara K, et al. (2008) An RNAi
Screen for Mitochondrial Proteins Required to Maintain the Morphology of the
Organelle in Caenorhabditis elegans. Journal of Biochemistry 143: 449–454.
52. Starr DA, Han M (2002) Role of ANC-1 in Tethering Nuclei to the Actin
Cytoskeleton. Science 298: 406–409.
53. Iwai T, Tanonaka K, Inoue R, Kasahara S, Motegi K, et al. (2002) Sodium
accumulation during ischemia induces mitochondrial damage in perfused rat
hearts. Cardiovasc Res 55: 141–149.
54. Jospin M, Mariol MC, Segalat L, Allard B (2004) Patch clamp study of the
UNC-105 degenerin and its interaction with the LET-2 collagen in
Caenorhabditis elegans muscle. J Physiol 557: 379–388.
55. Broday L, Kolotuev I, Didier C, Bhoumik A, Podbilewicz B, et al. (2004) The
LIM domain protein UNC-95 is required for the assembly of muscle attachment
structures and is regulated by the RING finger protein RNF-5 in C. elegans. The
Journal of Cell Biology 165: 857–867.
56. Kovacs AL, Gordon PB, Grotterod EM, Seglen PO (1998) Inhibition of
hepatocytic autophagy by adenosine, adenosine analogs and AMP. Biol Chem
379: 1341–1347.
57. Syntichaki P, Xu K, Driscoll M, Tavernarakis N (2002) Specific aspartyl and
calpain proteases are required for neurodegeneration in C. elegans. Nature 419:
939–944.
58. Fox RM, Watson JD, Von Stetina SE, McDermott J, Brodigan TM, et al. (2007)
The embryonic muscle transcriptome of Caenorhabditis elegans. Genome Biol
8: R188.
59. Etheridge T, Nemoto K, Hashizume T, Mori C, Sugimoto T, et al. (2011) The
Effectiveness of RNAi in Caenorhabditis elegans Is Maintained during
Spaceflight. PLoS ONE 6: e20459. doi:10.1371/journal.pone.0020459.
60. Lebart MC, Benyamin Y (2006) Calpain involvement in the remodeling of
cytoskeletal anchorage complexes. FEBS J 273: 3415–3426.
61. Beckmann JS, Spencer M (2008) Calpain 3, the ‘‘gatekeeper’’ of proper
sarcomere assembly, turnover and maintenance. Neuromuscul Disord 18:
913–921.
62. Ojima K, Kawabata Y, Nakao H, Nakao K, Doi N, et al. (2010) Dynamic
distribution of muscle-specific calpain in mice has a key role in physical-stress
adaptation and is impaired in muscular dystrophy. The Journal of Clinical
Investigation 120: 2672–2683.
63. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, et al.
(1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular
dystrophy type 2A. Cell 81: 27–40.
64. Charton K, Danie `le N, Vihola A, Roudaut C, Gicquel E, et al. (2010) Removal
of the calpain 3 protease reverses the myopathology in a mouse model for
titinopathies. Human Molecular Genetics 19: 4608–4624.
65. Francis R, Waterston RH (1991) Muscle cell attachment in Caenorhabditis
elegans. J Cell Biol 114: 465–479.
66. Hresko MC, Schriefer LA, Shrimankar P, Waterston RH (1999) Myotactin, a
novel hypodermal protein involved in muscle-cell adhesion in Caenorhabditis
elegans. J Cell Biol 146: 659–672.
67. Hall DH, Altun ZF (2008) C. elegans Atlas: Cold Spring Harbor Laboratory
press.
68. Belkin AM, Retta SF, Pletjushkina OY, Balzac F, Silengo L, et al. (1997) Muscle
beta1D integrin reinforces the cytoskeleton-matrix link: modulation of integrin
adhesive function by alternative splicing. J Cell Biol 139: 1583–1595.
69. Giannone G, Sheetz MP (2006) Substrate rigidity and force define form through
tyrosine phosphatase and kinase pathways. Trends Cell Biol 16: 213–223.
70. Byerly L, Cassada RC, Russell RL (1976) The life cycle of the nematode
Caenorhabditis elegans. I. Wild-type growth and reproduction. Dev Biol 51:
23–33.
71. Krause M (1995) MyoD and myogenesis in C. elegans. Bioessays 17: 219–228.
72. Harfe BD, Branda CS, Krause M, Stern MJ, Fire A (1998) MyoD and the
specification of muscle and non-muscle fates during postembryonic development
of the C. elegans mesoderm. Development 125: 2479–2488.
73. Ghosh SR, Hope IA (2010) Determination of the mobility of novel and
established Caenorhabditis elegans sarcomeric proteins in vivo. Eur J Cell Biol
89: 437–448.
74. Rogalski TM, Gilchrist EJ, Mullen GP, Moerman DG (1995) Mutations in the
unc-52 gene responsible for body wall muscle defects in adult Caenorhabditis
elegans are located in alternatively spliced exons. Genetics 139: 159–169.
75. Spartz AK, Herman RK, Shaw JE (2004) SMU-2 and SMU-1, Caenorhabditis
elegans homologs of mammalian spliceosome-associated proteins RED and
fSAP57, work together to affect splice site choice. Mol Cell Biol 24: 6811–6823.
76. Sorimachi H, Hata S, Ono Y (2010) Expanding members and roles of the
calpain superfamily and their genetically modified animals. Exp Anim 59:
549–566.
77. Kammenga JE, Doroszuk A, Riksen JA, Hazendonk E, Spiridon L, et al. (2007)
A Caenorhabditis elegans wild type defies the temperature-size rule owing to a
single nucleotide polymorphism in tra-3. PLoS Genet 3: e34. doi:10.1371/
journal.pgen.0030034.
78. Mackenzie Jr. JM, Garcea RL, Zengel JM, Epstein HF (1978) Muscle
development in Caenorhabditis elegans: Mutants exhibiting retarded sarcomere
construction. Cell 15: 751–762.
79. Kimura K, Tanaka N, Nakamura N, Takano S, Ohkuma S (2007) Knockdown
of Mitochondrial Heat Shock Protein 70 Promotes Progeria-like Phenotypes in
Caenorhabditis elegans. Journal of Biological Chemistry 282: 5910–5918.
80. Margalit A, Neufeld E, Feinstein N, Wilson KL, Podbilewicz B, et al. (2007)
Barrier to autointegration factor blocks premature cell fusion and maintains
adult muscle integrity in C. elegans. The Journal of Cell Biology 178: 661–673.
81. Crameri RM, Aagaard P, Qvortrup K, Langberg H, Olesen J, et al. (2007)
Myofibre damage in human skeletal muscle: effects of electrical stimulation
versus voluntary contraction. The Journal of Physiology 583: 365–380.
82. Mayer U, Saher G, Fassler R, Bornemann A, Echtermeyer F, et al. (1997)
Absence of integrin [alpha]7 causes a novel form of muscular dystrophy. Nat
Genet 17: 318–323.
83. Shaye DD, Greenwald I (2011) OrthoList: A Compendium of C. elegans Genes
with Human Orthologs. PLoS ONE 6: e20085. doi:10.1371/journal.
pone.0020085.
84. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71–94.
85. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, et al. (1998) Potent and
specific genetic interference by double-stranded RNA in Caenorhabditis elegans.
Nature 391: 806–811.
86. Benedetti C, Haynes CM, Yang Y, Harding HP, Ron D (2006) Ubiquitin-like
protein 5 positively regulates chaperone gene expression in the mitochondrial
unfolded protein response. Genetics 174: 229–239.
Calpain-Mediated Muscle Repair
PLoS Genetics | www.plosgenetics.org 19 January 2012 | Volume 8 | Issue 1 | e100247187. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, et al.
(2000) Functional genomic analysis of C. elegans chromosome I by systematic
RNA interference. Nature 408: 325–330.
88. Chen N, Harris TW, Antoshechkin I, Bastiani C, Bieri T, et al. (2005)
WormBase: a comprehensive data resource for Caenorhabditis biology and
genomics. Nucleic Acids Res 33: D383–389.
89. Rual JF, Ceron J, Koreth J, Hao T, Nicot AS, et al. (2004) Toward improving
Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi
library. Genome Res 14: 2162–2168.
90. Lin JJ (1981) Monoclonal antibodies against myofibrillar components of rat
skeletal muscle decorate the intermediate filaments of cultured cells. Proc Natl
Acad Sci U S A 78: 2335–2339.
91. Francis GR, Waterston RH (1985) Muscle organization in Caenorhabditis
elegans: localization of proteins implicated in thin filament attachment and I-
band organization. J Cell Biol 101: 1532–1549.
Calpain-Mediated Muscle Repair
PLoS Genetics | www.plosgenetics.org 20 January 2012 | Volume 8 | Issue 1 | e1002471